Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation therapy for retroperitoneal sarcoma.

Ching-Wei D Tzeng1, John B Fiveash, Martin J Heslin

  • 1Surgical Oncology Research Fellow, Department of Surgery, University of Alabama-Birmingham, Birmingham, AL, USA. cdt99@uab.edu

Expert Review of Anticancer Therapy
|August 24, 2006
PubMed
Summary

Complete surgical removal is standard for retroperitoneal soft-tissue sarcoma, but local recurrence remains a challenge. Adjuvant radiation therapy shows promise for local control, though optimal strategies require further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How I Use the Fourth Arm in Robotic Pancreatoduodenectomy.

Journal of hepato-biliary-pancreatic sciences·2026
Same author

ASO Visual Abstract: Longitudinal Symptom Recovery After Pancreatectomy-A Prospective Patient-Reported Outcomes Study using MDASI.

Annals of surgical oncology·2026
Same author

5x-Multiplier Versus 3-Tier Model: A Pragmatic Randomized Clinical Trial for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery.

Annals of surgery·2026
Same author

Longitudinal Symptom Recovery After Pancreatectomy: A Prospective Patient-Reported Outcomes Study using MDASI.

Annals of surgical oncology·2026
Same author

Impact of Distance From the Isocenter on Local Control and Toxicity for Zero Margin, Single-Isocenter Multitarget Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Brain Metastases.

International journal of radiation oncology, biology, physics·2026
Same author

Opinion: a call for safe therapeutic and gastric interventions for adolescents and young adults with obesity and transplant-indicated leukemia.

Frontiers in oncology·2026

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Retroperitoneal soft-tissue sarcoma is a rare cancer originating from mesodermal tissues.
  • Its anatomical location near vital structures complicates treatment and increases the risk of local recurrence.
  • Complete surgical resection is the current standard of care, impacting overall survival.

Purpose of the Study:

  • To review the current treatment landscape for retroperitoneal soft-tissue sarcoma.
  • To evaluate the role of adjuvant radiation therapy in improving local control.
  • To identify challenges and future directions in optimizing treatment protocols.

Main Methods:

  • Review of existing literature and institutional series on retroperitoneal soft-tissue sarcoma management.

Related Experiment Videos

  • Analysis of the impact of surgical resection and adjuvant therapies on patient outcomes.
  • Discussion of radiation therapy techniques, timing, and toxicity concerns.
  • Main Results:

    • Complete gross resection is the only treatment shown to improve overall survival for this sarcoma.
    • Local recurrence, not distant metastasis, is the primary cause of mortality.
    • Adjuvant radiation therapy has demonstrated potential in improving local control in various studies.

    Conclusions:

    • While adjuvant radiation therapy shows promise for local control, definitive evidence from prospective randomized trials is lacking.
    • Significant radiation-related toxicities, particularly to the small bowel, necessitate careful consideration of timing, delivery, and dosage.
    • Further research is crucial to establish optimal radiation strategies that balance efficacy with acceptable toxicity for retroperitoneal soft-tissue sarcoma.